Three-dimensional ultrasound evaluation of the efficacy and safety of single-dose systemic or local methotrexate injection for tubal pregnancy

Abstract

Abstract: Objective To compare the efficacy and safety of single-dose systemic and local injection of methotrexate (MTX) in the treatment of tubal pregnancy (TP).Methods The systemic group included 127 women with TP who received a single-dose MTX of 50mg/m² given by intramuscular injection,and the local group included 118 women receiving single-dose MTX of 100 mg via local injection guided by three-dimensional (3D) ultrasound. The volume of ectopic masses and blood β-human chorionic gonadotropin (β-HCG) were measured before and after MTX administration. The TP was detected by 3D images reconstructed 3 months after MTX administration. Results The success rate of treatment was 100% in the local group,signi- ficantly higher than that of 91.34% in the systemic group. After the first week of MTX injection,the speed of the ectopic mass resolution was 0.85±0.04cm³/d and 0.47±0.03cm³/d in systemic group and local group respectively (P<0.05),and the time of the ectopic mass resolution was 27.66±12.77 d and 32.62±12.75 d,respectively (P<0.01). The rate of tubal deformity in the local group was significantly lower than that in the systemic group.Conclusion Local injection of MTX under ultrasound guidance is safe,efficient and reliable for conservative management of unruptured TP,which is superior to systemic injection.

CLC Number:

R714.221

CAO Xiao-hua¹, LI Hui². Three-dimensional ultrasound evaluation of the efficacy and safety of single-dose systemic or local methotrexate injection for tubal pregnancy[J]. Journal of Southern Medical University, 2004, 24(10): 1201-1202.

References

[1] Glock JL,Johnson JV,Brumsted JR.Efficacy and safety of single dose systemic methotrexate in the treatment of ectopic pregnancy[J].Fertil Steril,1994,62(4):716-21.
[2] Feichtinger W,Kemeter P.Conservative treatment of ectopic pregnancy by transvaginal aspiration under sonographic control and methotrate injection [J].Lancet,1987; 1 (8529):381-2.
[3] Kremer JM,Galivan J,Streckfuss A,et al.Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients [J].Arthritis Rheum,1986,29(7):832-5.
[4] Glock JL,Johnson JV,Brumsted JR.Efficacy and safety of singledose systemic methotrexate in the treatment of ectopic pregnancy[J].Fertil Steril,1994,62(4):716-21.
[5] Merz E,Bahlmann F,Weber G,et al.Unruptured tubal pregnancy:local low-dose therapy with methotrexate under transvaginal ultrasonographic guidance [J].Gynecol Obstet Invest,1996,41 (2):76-81.
[6] Fernandez H,Baton C,Lelaidier C,et al.Conservative management of ectopic pregnancy:prospective randomized clinical trial of methotrexate versus prostaglandin sulprostone by combined transvaginal and systemic administration[J].Fertil Steril,1991,55(4):746-50.
[7] Kucera E,Schindl M,Klem I,et al.Could we treat more unruptured ectopic preganancies with intramuscular methotrexate [J] ? Gynecol Obstet Invest (Switzerland),2000,49(1):6-11.
[8] Tzafettas JM,Stephanatos A,Loufopoulos A,et al.Single high dose of local methotrexate for the management of relatively advanced ectopic pregnancies[J].Fertil Steril,1999,71(6):1010-3.
[9] Gamzu R,Almog B,Levin Y,et al.The ultrasonographic appearance of tubal pregnancy in patients treated with methotrexate [J].Hum Reprod,2002,17(10):2585-7.
[10] Menard A,Crequat J,Mandelbrot L,et al.Treatment of unruptured tubal pregnancy by local injection of methotrexate under transvaginal sonographic control[J].Fertil Steril,1990,54(1):47-50.